Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 450 Day CR rate

<< Previous

Bullboard Posts

Next >>

Post by Eoganachton Sep 02, 2023 5:56pm

468 Views

Post# 35617699

450 Day CR rate

Looking at the new swimmer's plot - there is 1 CR patient at 360 days awaiting their 450 day assessment. There are also 3 CR patients at 270 days and 4 CR patients at 180 days awaiting further assessment. All of these patients have had a CR since they were first tested. In 9 months, if they all maintain their CRs we will have a 40% CR rate at 450 days.

<< Previous

Bullboard Posts

Next >>

AI companies to invest in